The mutual interplay of gut microbiota, diet and human disease

P Illiano, R Brambilla, C Parolini - The FEBS journal, 2020 - Wiley Online Library
The intestinal milieu harbours the gut microbiota, consisting of a complex community of
bacteria, archaea, fungi, viruses and protozoans that bring to the host organism an …

Effects of fish n-3 PUFAs on intestinal microbiota and immune system

C Parolini - Marine drugs, 2019 - mdpi.com
Studies over several decades have documented the beneficial actions of n-3
polyunsaturated fatty acids (PUFAs), which are plentiful in fish oil, in different disease states …

Regulatory genomic circuitry of human disease loci by integrative epigenomics

CA Boix, BT James, YP Park, W Meuleman, M Kellis - Nature, 2021 - nature.com
Annotating the molecular basis of human disease remains an unsolved challenge, as 93%
of disease loci are non-coding and gene-regulatory annotations are highly incomplete …

The gut microbiota affects host pathophysiology as an endocrine organ: A focus on cardiovascular disease

M Busnelli, S Manzini, G Chiesa - Nutrients, 2019 - mdpi.com
It is widely recognized that the microorganisms inhabiting our gastrointestinal tract—the gut
microbiota—deeply affect the pathophysiology of the host. Gut microbiota composition is …

Lysophosphatidic acid, a simple phospholipid with myriad functions

K Yanagida, T Shimizu - Pharmacology & Therapeutics, 2023 - Elsevier
Lysophosphatidic acid (LPA) is a simple phospholipid consisting of a phosphate group,
glycerol moiety, and only one hydrocarbon chain. Despite its simple chemical structure, LPA …

Dietary components regulate chronic diseases through gut microbiota: a review

Y Zhang, M Zhou, Y Zhou… - … of the Science of Food and …, 2023 - Wiley Online Library
In recent years, gut microbiota as an immune organ has gradually become the mainstream
of research. When the composition of the gut microbiota is changed significantly, this may …

Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease

Y Zhou, PJ Little, HT Ta, S Xu, D Kamato - Pharmacology & Therapeutics, 2019 - Elsevier
Lysophosphatidic acid (LPA) is a collective name for a set of bioactive lipid species. Via six
widely distributed G protein-coupled receptors (GPCRs), LPA elicits a plethora of biological …

[HTML][HTML] Molecular mechanisms and genetic regulation in atherosclerosis

AO Jackson, MA Regine, C Subrata, S Long - IJC heart & vasculature, 2018 - Elsevier
Atherosclerosis (AS) manifested by lipid accumulation, extracellular matrix protein
deposition, and calcification in the intima and media of the large to medium size arteries …

Melatonin ameliorates simulated‐microgravity‐induced mitochondrial dysfunction and lipid metabolism dysregulation in hepatocytes

Y Xiong, C Ma, Q Li, W Zhang, H Zhao… - The FASEB …, 2023 - Wiley Online Library
The liver is an essential multifunctional organ, which constantly communicates with nearly
all tissues. It has raised the concern that microgravity exposure can lead to liver dysfunction …

Coronary Artery Disease Risk-Associated Plpp3 Gene and Its Product Lipid Phosphate Phosphatase 3 Regulate Experimental Atherosclerosis

PA Mueller, L Yang, M Ubele, G Mao… - … , and vascular biology, 2019 - Am Heart Assoc
Objective: Genome-wide association studies identified novel loci in PLPP3 (phospholipid
phosphatase 3) that associate with coronary artery disease risk independently of traditional …